News

Future Diagnostics is proudly announcing the PhD promotion of Giuliana Ascone. Giuliana was ESR in the Marie Curie Euroclast project supported by Future Diagnostics and working at the Department of Experimental Rheumatology of the Radboud University.

Future Diagnostics Solutions B.V. is proud to announce the successful completion of its fifth Food and Drug Administration (FDA) inspection last month. The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices.

Sensing technologies for acquiring real-time, precise, and reliable data are becoming more and more important in the field of healthcare, to help monitor, treat and coach patients. Future Diagnostics Solutions is proud to be a partner in the TTW funded Biomonitor project aiming at the development of continuous monitoring sensors.

After last year’s successful edition we are proud to be organizing our second IVDR & Immunoassays Mini Symposium on Wednesday November 20th, 2019 from 9 am to 10.30 am at MEDICA.

We were proud to be a partner of SensUs. SensUs believes that collaboration and information sharing on a worldwide scale is very important for innovation in the field of biosensors.

The FDA warns that biotin may interfere with lab tests.

Biotin is a vitamin that can be found in (multi-vitamin) pills or supplements for hair, skin, and nail growth. More and more people take or consider taking these pills or supplements. However, this biotin can significantly interfere with certain laboratory test and may cause test results that are incorrect.

Accuspheres are formed by combining a suitable matrix with the component of interest. This solution (minimal of 50 μl) is dripped into liquid nitrogen followed by a freeze-drying process, which forms the stable sphere.

We wish our customers, colleagues, partners and other stakeholders the best of joy and cheer for Christmas and the coming year.